Orthofix Medical Inc. Long-term Line of Credit
Orthofix Medical Inc. (OFIX) had Long-term Line of Credit of $125.00 million as of 2024-11-07, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2026-02-24
- 2024-11-07: Long-term Line of Credit $125.00M.
- 2017-09-30: Long-term Line of Credit $0.00.
- 2017-06-30: Long-term Line of Credit $0.00.
- 2017-03-31: Long-term Line of Credit $0.00.
| Period end | Long-term Line of Credit |
|---|---|
| 2024-11-07 | $125.00M 10-K · filed 2026-02-24 |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-30 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 |
| 2016-09-30 | $0.00 10-Q · filed 2016-10-31 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-01 |
| 2016-03-31 | $0.00 10-Q · filed 2016-04-28 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-03 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-04 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-18 |
| 2014-12-31 | $0.00 10-K · filed 2015-04-29 |
| 2014-09-30 | $0.00 10-Q · filed 2015-03-31 |
| 2013-12-31 | $0.00 10-Q · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |